Literature DB >> 22198706

The complex intratumoral heterogeneity of colon cancer highlighted by laser microdissection.

David Buob1, Harold Fauvel, Marie-Pierre Buisine, Stéphanie Truant, Christophe Mariette, Nicole Porchet, Agnès Wacrenier, Marie-Christine Copin, Emmanuelle Leteurtre.   

Abstract

AIMS: To evaluate the utility of laser microdissection in the comparison of phenotypes and genetic alterations between colon cancer and corresponding liver metastasis in the context of intratumoral heterogeneity.
METHODS: Immunohistochemistry was performed on a series of 11 patients surgically treated for colon adenocarcinoma with liver metastases, using antibodies directed against six mucins. Immunohistochemistry was completed by laser microdissection of tumor zones with particular phenotype, luminal zone and invasion front of colon tumors. Microdissected samples were compared on the basis of microsatellite instability and alterations of CTNNB1, KRAS, and TP53.
RESULTS: Our study demonstrated varying mucin expression within tumors, suggesting the existence of phenotypic intratumoral heterogeneity. A common immunohistochemical profile was observed in individual tumors between tumoral subpopulations and corresponding metastases. Nevertheless, the phenotypic characteristics were distinct from one patient to another. Laser microdissection underlined that phenotypic heterogeneity could rely on genotypic heterogeneity, and that some genetic alterations were common to microdissected samples from primary colon tumors and liver metastases.
CONCLUSION: We illustrated intratumoral heterogeneity of colon cancer using laser microdissection, in combination with immunohistochemical and genotypic tools. This intratumoral heterogeneity could represent a major issue in the search of prognostic biomarkers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22198706     DOI: 10.1007/s10620-011-2023-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

1.  MUC5AC, but not MUC2, is a prominent mucin in respiratory secretions.

Authors:  H W Hovenberg; J R Davies; A Herrmann; C J Lindén; I Carlstedt
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

2.  Molecular staging for survival prediction of colorectal cancer patients.

Authors:  Steven Eschrich; Ivana Yang; Greg Bloom; Ka Yin Kwong; David Boulware; Alan Cantor; Domenico Coppola; Mogens Kruhøffer; Lauri Aaltonen; Torben F Orntoft; John Quackenbush; Timothy J Yeatman
Journal:  J Clin Oncol       Date:  2005-05-20       Impact factor: 44.544

3.  KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

Authors:  Astrid Lièvre; Jean-Baptiste Bachet; Delphine Le Corre; Valérie Boige; Bruno Landi; Jean-François Emile; Jean-François Côté; Gorana Tomasic; Christophe Penna; Michel Ducreux; Philippe Rougier; Frédérique Penault-Llorca; Pierre Laurent-Puig
Journal:  Cancer Res       Date:  2006-04-15       Impact factor: 12.701

Review 4.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Authors:  C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

5.  Diagnostic value of MUC4 immunostaining in distinguishing epithelial mesothelioma and lung adenocarcinoma.

Authors:  Karine Llinares; Fabienne Escande; Sébastien Aubert; Marie-Pierre Buisine; Carme de Bolos; Surinder K Batra; Bernard Gosselin; Jean-Pierre Aubert; Nicole Porchet; Marie-Christine Copin
Journal:  Mod Pathol       Date:  2004-02       Impact factor: 7.842

Review 6.  Mucins and mucin binding proteins in colorectal cancer.

Authors:  James C Byrd; Robert S Bresalier
Journal:  Cancer Metastasis Rev       Date:  2004 Jan-Jun       Impact factor: 9.264

7.  Expression of mucins and cytokeratins in primary carcinomas of the digestive system.

Authors:  Min Jong Lee; Hye Seung Lee; Woo Ho Kim; Yunhee Choi; Mihi Yang
Journal:  Mod Pathol       Date:  2003-05       Impact factor: 7.842

8.  Intratumoral heterogeneity of genetic changes in primary colorectal carcinomas with metastasis.

Authors:  Hiroyuki Fukunari; Takeo Iwama; Ken-ichi Sugihara; Michiko Miyaki
Journal:  Surg Today       Date:  2003       Impact factor: 2.549

9.  Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis.

Authors:  R S Bresalier; Y Niv; J C Byrd; Q Y Duh; N W Toribara; R W Rockwell; R Dahiya; Y S Kim
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

Review 10.  Preparing the "soil": the premetastatic niche.

Authors:  Rosandra N Kaplan; Shahin Rafii; David Lyden
Journal:  Cancer Res       Date:  2006-12-01       Impact factor: 12.701

View more
  7 in total

1.  Low percentage of KRAS mutations revealed by locked nucleic acid polymerase chain reaction: implications for treatment of metastatic colorectal cancer.

Authors:  Mariella Dono; Carlotta Massucco; Silvana Chiara; Claudia Sonaglio; Marco Mora; Anna Truini; Giannamaria Cerruti; Gabriele Zoppoli; Alberto Ballestrero; Mauro Truini; Manlio Ferrarini; Simona Zupo
Journal:  Mol Med       Date:  2013-02-08       Impact factor: 6.354

2.  Optimal detection of clinically relevant mutations in colorectal carcinoma: sample pooling overcomes intra-tumoral heterogeneity.

Authors:  Andrew C Nelson; Jamie Boone; David Cartwright; Bharat Thyagarajan; Robyn Kincaid; Aaron P Lambert; Kylene Karnuth; Christine Henzler; Sophia Yohe
Journal:  Mod Pathol       Date:  2017-10-13       Impact factor: 7.842

3.  Multi-level interactions between the nuclear receptor TRα1 and the WNT effectors β-catenin/Tcf4 in the intestinal epithelium.

Authors:  Maria Sirakov; Seham Skah; Imtiaz Nisar Lone; Julien Nadjar; Dimitar Angelov; Michelina Plateroti
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

4.  Mathematical modelling identifies conditions for maintaining and escaping feedback control in the intestinal epithelium.

Authors:  Matthias M Fischer; Hanspeter Herzel; Nils Blüthgen
Journal:  Sci Rep       Date:  2022-04-02       Impact factor: 4.996

5.  Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer.

Authors:  Sakarias Wangefjord; Jenny Brändstedt; Kajsa Ericson Lindquist; Björn Nodin; Karin Jirström; Jakob Eberhard
Journal:  Diagn Pathol       Date:  2013-01-21       Impact factor: 2.644

Review 6.  Zebrafish as a model to assess cancer heterogeneity, progression and relapse.

Authors:  Jessica S Blackburn; David M Langenau
Journal:  Dis Model Mech       Date:  2014-07       Impact factor: 5.758

7.  High-Precision Quantitative Analysis Reveals Carcinoembryonic Protein Expression Differs Among Colorectal Cancer Primary Foci and Metastases to Different Sites.

Authors:  Yazhen Zhu; Qin Zhang; Chengjiang Wei; Ying Hu; Han Gong; Yi Liu; Hao Lai; Yan Feng; Yuan Lin
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.